Page 240 - fbkCardioDiabetes_2017
P. 240

216                      Obstructive Sleep Apnoea Syndrome
                                                  and Cardio Metabolic Risk



              Because  of the  consequences of OSAS,  the issue   predictor for OSAS.
              of screening for OSAS in asymptomatic patients has
              been assessed by  Shafazand  [6]  and he concluded  The role of ICT
              that there is insufficient evidence for this to be rou-  New  developments in technology have  been incor-
              tinely done.
                                                                 porated in the diagnosis and management of OSAS.
              Diagnostic tools                                   Koo et.al [14] have investigated the usefulness of re-
                                                                 cording snoring  sounds with  the  smartphone which
              In  symptomatic patients, the  Epworth  sleepiness   are then analysed acoustically to determine the site
              score has been traditionally used.
                                                                 of obstruction in OSAS. It was found that retropala-
              The  STOP-Bang questionnaire  [7] tool can also be   tal level of obstruction tended to produce sharp and
              applied  as a reliable,  concise  and  easy-to-use  tool.   regular peaks while retrolingual obstruction tended to
              Snoring, Tiredness, Observed apnoea, high BP, BMI,   show peaks with a gradual onset and decay. Acous-
              Age,  Neck circumference  and male  Gender are the   tic  analysis  is  non-invasive  and  can  be applied  at  a
              parameters assessed.                               relatively low cost.
              Prudon et.al. used a novel postal –based approach to   Coma-del-Coral et al [15] have assessed the reliabili-
              diagnose  OSAS in a high-risk  patients. [8].  Patients   ty of telemedicine in the diagnosis and treatment of
              who interested in participating in the study were sent   OSAS. Forty patients were studied from a population
              a four-channel device (Apnea Link [AL}, ResMed, UK)   80km away using respiratory polygraphy transmitted
              via the post  with pictorial  and written instructions.   in real time. The level of compliance with the resultant
              Following a single night study the AL device was re-  CPAP treatment in a conventional clinic was 85% and
              turned via a freepost service. 75% of the studies could   75% in those seen  by teleconsultation  suggesting
              be  analyzed,  suggesting  that this approach  may be   that is a useful application.
              useful in clinic practice, avoiding clinic attendance.
                                                                 CPAP is the most commonly used option for OSAS,
              Full PSG testing can sometimes be economically and   however  it  is  not always  clear  how compliant is  the
              logistically difficult and Chai-Coetzer & McEvoy have   patient. There was evaluation of the add-on NOWAPI
              concluded  that  simplified  cardiorespiratory  sleep   medical device for remote monitoring of compliance
              tests are a reliable, cost-saving option for diagnos-  to CPAP and treatment efficacy in OSA [16].
              ing OSAS. [9]
                                                                 The findings suggest  that  the  NOWAPI estimate of
                                                                 CPAP treatment was clinically accurate and in agree-
              Biomarkers in OSAS                                 ment with polygraphy.
              Kheerandish-Gazal & Gozal [10] have given a succinct
              overview  of morbidity  biomarkers  that  have been   Phenotyping of OSAS
              identified  in Paediatric OSAS  which  would circum-  OSAS  is  a complex  disease  and Zinchuk  et  al  [17]
              vent labour-intensive and onerous steps in diagnos-  have  made a case for enhanced  phenotyping.  The
              ing OSAS and its morbidities.
                                                                 OSA  phenotype  can  be  defined  as  “  A  category  of
              Erdim et.al [11]  found  that  the Mean platelet volume   patients with OSA distinguished from others by a sin-
              (MPV), neutrophil-to-lymphocyte (NLR) and plate-   gle or combination of disease features, in relation to
              let-to-lymphocyte ratio (PLR) were significantly high-  clinically meaningful attributes (symptoms, response
              er in children whose AHI was >5 than in children in   to therapy,  health outcomes, quality  of life)”.  Better
              other groups.                                      phenotyping improve can many aspects of diagnosis,
                                                                 understanding of the pathophysiology and personal-
              Li et al [12]  have  done a meta-analysis on CRP  lev-  ization of treatment for OSAS patients.
              els and found that the level in the OSAS group was
              1.98mmol/l higher than in the control group. This find-  The use of Network science and applying it to respi-
              ing is consistent with the inflammatory component of   ratory medicine can lead to improved OSAS pheno-
              OSAS and supports the role of CRP as a biomarker   typing and severity prediction according to Mihaicuta
              in this disease.                                   et al [18]
              Atan et al [13] looked at 336 patients and the Mono-
              cyte to HDL  Ratio (MHR) was assessed  and com-    Pathophysiology & Complications of OSAS
              pared  between the OSAS  subjects and  controls. It   OSAS has a deleterious effect on almost all aspects
              was found  that  MHR  was significantly higher  in pa-  of life,  including  cardio-metabolic  complications
              tients with OSAS and can possibly be a new, useful   which can be life threatening.


                                                         GCDC 2017
   235   236   237   238   239   240   241   242   243   244   245